Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0603297 on December 12, 2003

Published online before print December 12, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0603297v1
75/3/443    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X.
Right arrow Articles by Thorlacius, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X.
Right arrow Articles by Thorlacius, H.
Related Collections
Right arrowRelated Articles
(Journal of Leukocyte Biology. 2004;75:443-452.)
© 2004 by Society for Leukocyte Biology

Critical role of CXC chemokines in endotoxemic liver injury in mice

Xiang Li, Daniel Klintman, Qing Liu, Tohru Sato, Bengt Jeppsson and Henrik Thorlacius1

Department of Surgery, Malmö University Hospital, Lund University, Sweden

1Correspondence: Department of Surgery, Malmö University Hospital, Lund University, S-205 02 Malmö, Sweden. E-mail: henrikthorlacius{at}hotmail.com


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Tissue accumulation of leukocytes constitutes a rate-limiting step in endotoxin-induced tissue injury. Chemokines have the capacity to regulate leukocyte trafficking. However, the role of CXC chemokines, i.e., macrophage inflammatory protein-2 (MIP-2) and cytokine-induced neutrophil chemoattractant (KC), in leukocyte recruitment, microvascular perfusion failure, cellular injury, and apoptosis in the liver remains elusive. Herein, mice were challenged with lipopolysaccharide (LPS) in combination with D-galactosamine, and intravital microscopy of the liver microcirculation was conducted 6 h later. It was found that immunoneutralization of MIP-2 and KC did not reduce LPS-induced leukocyte rolling and adhesion in postsinusoidal venules. In contrast, pretreatment with monoclonal antibodies against MIP-2 and KC abolished (83% reduction) extravascular recruitment of leukocytes in the livers of endotoxemic mice. Notably, endotoxin challenge increased the expression of CXC chemokines, which was mainly confined to hepatocytes. Moreover, endotoxin-induced increases of liver enzymes and hepatocellular apoptosis were decreased by more than 82% and 68%, respectively, and sinusoidal perfusion was restored in mice passively immunized against MIP-2 and KC. In conclusion, this study indicates that intravascular accumulation of leukocytes in the liver is independent of CXC chemokines in endotoxemic mice. Instead, our novel data suggest that CXC chemokines are instrumental in regulating endotoxin-induced transmigration and extravascular tissue accumulation of leukocytes. Indeed, these findings demonstrate that interference with MIP-2 and KC functions protects against septic liver damage and may constitute a potential therapeutic strategy to control pathological inflammation in endotoxemia.

Key Words: adhesion • endotoxin • intravital microscopy • sepsis • transmigration


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Leukocyte recruitment is a rate-limiting step in endotoxemic liver injury [1 2 3 ]. It has been shown that hepatic infiltration of leukocytes comprises a multistep process in which the initial adhesive rolling interaction is a precondition for the subsequent firm adhesion of leukocytes in postsinusoidal venules [3 ]. Moreover, we have recently demonstrated that leukocyte rolling in postsinusoidal venules is predominately mediated by the selectin family of adhesion molecules [3 ]. In fact, we have found that leukocyte rolling is mainly dependent on P-selectin function in the liver [4 ]. Firm adhesion of leukocytes to the microvascular endothelium is dependent on the function of ß2-integrins on leukocytes, interacting with members of the immunoglobulin (Ig) supergene family expressed on endothelial cells, such as intercellular adhesion molecule-1 [5 ]. Finally, to transmigrate out of the microvasculature, leukocytes need to deform to penetrate through the interendothelial cell junctions. Although the adhesive pathways supporting leukocyte rolling and adhesion are well established, the molecules mediating transendothelial migration of leukocytes remain elusive. Platelet-endothelial cell adhesion molecule-1 (PECAM-1) has been forwarded as one candidate in the mesentery [6 ], although a role of PECAM-1 for leukocyte extravasation in liver microvessels remains to be demonstrated. In fact, Chosay et al. [7 ] demonstrated that immunoneutralization of PECAM-1 was ineffective in inhibiting leukocyte transmigration and hepatic injury induced by endotoxin. Nonetheless, it has been suggested that the transmigration out into the extravascular space is necessary for leukocytes to cause significant liver damage [8 ].

Activation and tissue navigation of leukocytes are coordinated by secreted chemokines [9 10 11 ]. The chemokine family includes small peptides that are known to be key regulators of leukocyte activation and tissue accumulation [9 10 11 ]. The members of this family are subdivided into two main groups (CC and CXC) based on structural properties. In the mouse, the CXC chemokine family includes macrophage inflammatory protein-2 (MIP-2) [12 ] and cytokine-induced neutrophil chemoattractant (KC) [9 13 ]. MIP-2 and KC are known to be murine homologues of human growth-related oncogene chemokines [11 12 ]. The CXC chemokines are considered to attract predominately neutrophils [9 10 11 ] and have been implicated as important mediators of several severe conditions, such as endotoxemia-induced lung injury [14 ], glomerulonephritis [15 ], bacterial meningitis [16 ], and hepatic ischemia-reperfusion [17 ]. Although numerous studies have demonstrated clear-cut inductions of CXC chemokines in livers of endotoxemic animals [18 19 ], the literature on the functional role of CXC chemokines in endotoxin-provoked leukocyte recruitment and liver injury is limited and contradictory. For example, one study showed that an antibody directed against the rat CXC chemokine cytokine-induced neutrophil chemoattractant reduced hepatic accumulation of neutrophils in endotoxemic rats [18 ]. In contrast, a recent study reported that immunoneutralization of MIP-2 or KC was ineffective against endotoxin-induced recruitment of neutrophils in the liver [20 ]. Moreover, it was recently demonstrated that systemic injection of CXC chemokines is a weak inducer of neutrophil sequestration in liver sinusoids and, in fact, lacks the capacity to induce margination of neutrophils in postsinusoidal venules [21 ]. Thus, a role of CXC chemokines in endotoxin-induced leukocyte recruitment and tissue injury in the liver remains to be documented. One reason for the controversy discussed above may be related to the fact that those studies were limited to morphological assessment of leukocyte recruitment. In this context, it is important to note that intravital microscopy is an important tool to define the role of specific molecules in leukocyte-endothelium interactions, enabling direct observation and quantification of the multiple steps of the extravasation process of leukocytes, including leukocyte rolling and adhesion.

Based on the above considerations, we wanted to define the role of CXC chemokines in leukocyte extravasation, microvascular perfusion, hepatocellular injury, and apoptosis in endotoxemic mice. For this purpose, we used intravital fluorescence microscopy of the liver microcirculation in combination with molecular and morphological techniques.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals
Adult male C57Bl/6 mice weighing 23–27 g were kept on a 12–12-h, light-dark cycle with free access to food and tap water. Animals were anesthetized by intraperitoneal (i.p.) administration of 7.5 mg ketamine hydrochloride (Xylazine, Hoffman-La Roche, Basel, Switzerland) and 2.5 mg Xylazine (Janssen Pharmaceutica, Beerse, Belgium) per 100 mg body weight. The right jugular vein was cannulated with a polyethylene catheter for intravenous (i.v.) administration of test substances, fluorescent dyes, and additional anesthesia. The local ethics committee approved all the experiments of this study.

Experimental protocol
To delineate the role of MIP-2 and KC in endotoxin-induced leukocyte recruitment and liver injury, monoclonal antibodies (mAb) directed against MIP-2 (40 µg per mouse, clone 40605.111, rat IgG, R & D Systems Europe, Abingdon, Oxon, UK) and/or KC (40 µg per mouse, clone 48415.111, rat IgG, R & D Systems Europe) and a control antibody (R3-34, rat IgG, PharMingen, San Diego, CA) were given i.v. immediately before endotoxin challenge. In separate experiments, these doses of anti-MIP-2 and -KC antibodies blocked leukocyte recruitment induced by MIP-2 and KC, respectively, by more than 93% in the mouse cremaster muscle. Six hours before surgery and intravital observation, mice were pretreated i.p. with or without (negative-control animals) a combination of lipopolysaccharide (LPS; 10 µg/mouse; Sigma Chemical Co., St. Louis, MO) and D-galactosamine (Gal; 18 mg/mouse; Sigma Chemical Co.), dissolved in phosphate-buffered saline (PBS) to a total volume of 0.25 ml.

Surgical procedure
Five hours and 40 min after administration of test substances, animals were anesthetized, a transverse subcostal incision was performed, and the ligamentous attachments from the liver to the diaphragm and the abdominal wall were gently released. The animals were positioned on their left side, and the left liver lobe was carefully exteriorized onto an adjustable stage for analysis of hepatic microcirculation by use of intravital fluorescence microscopy. The liver surface was covered with a circular glass to avoid tissue drying and exposure to ambient oxygen. An equilibration period of 5 min was allowed before starting microscopical observation. Fifteen minutes later, after intravital observations, animals were killed by exsanguination, and blood was drawn from the heart for analysis of liver function tests, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) using standard spectrophotometric procedures. Systemic leukocyte counts, including polymorphonuclear leukocytes (PMNL) and mononuclear leukocytes (MNL), were determined by use of a hematocytometer.

Intravital microscopy
For observations of the liver microcirculation, we used a modified Olympus microscope (BX50WI, Olympus Optical Co. GmbH, Hamburg, Germany) equipped with different water-immersion lenses (x40 NA 0.75/x63 NA 0.9). The image was televised (Sony Trinitron) using a charge-coupled device video camera (FK 6990 Cohu, Pieper GmbH, Schwerte, Germany) and recorded on videotape (Panasonic SVT-S3000 S-VHS recorder) for subsequent off-line evaluation. Perfusion within individual microvessels was studied after contrast enhancement by fluorescein isothiocyanate-dextran (0.1 ml, 2 µmol/kg; Sigma Chemical Co.). In vivo labeling of leukocytes with rhodamine-6G (0.1 ml, 0.05 mg/ml; Sigma Chemical Co.) enabled quantitative analysis of leukocyte flow behavior in sinusoids and postsinusoidal venules. Quantification of microcirculatory parameters was performed off-line by frame-to-frame analysis of the videotaped images. Five postsinusoidal venules with connecting sinusoids were evaluated in each animal. Microcirculatory analysis included determination of the number of perfused sinusoids given as a percentage of the total number of sinusoids observed (i.e., sinusoidal perfusion). Within postsinusoidal venules, leukocyte rolling was measured by counting the number of cells rolling in the venule during 30 s and is expressed as cells/min. Leukocyte adhesion was measured by counting the number of cells that adhered along the venular endothelium and remained stationary during the observation period of 30 s and is expressed as cells/mm venule length. Blood-flow velocities were measured off-line by use of CapImage software (Zeintl, Heidelberg, Germany). The velocity was calculated as a mean value from five measurements per venule and is expressed as mm/s. Venular wall shear rate was determined based on the Newtonian definition: Wall shear rate = 8 [(red blood cell velocity)/venular diameter], as described previously [22 ]. Wall shear stress was calculated according to the wall shear stress = wall shear rate x 0.025 (dyn/cm), assuming a blood viscosity of 0.025 poise. Hepatocyte apoptosis was measured in the same microscopic setup as above. For this purpose, the fluorochrome Hoechst 33342 (Hoechst, 0.02 ml, 0.2 µg/ml; Molecular Probes, Leiden, the Netherlands) was topically applied onto the liver surface for staining of hepatocyte DNA. Hoechst is a fluorescent dye that has been widely used for analysis of nuclear morphology, e.g., nuclear condensation and fragmentation in cultured hepatocytes and endothelial cells [23 ]. After exsanguination and 5 min of incubation, six microscopical fields (using a x63 lens) were recorded for off-line quantification of hepatocyte nuclei showing signs of apoptosis (chromatin condensation and fragmentation). Hepatocyte apoptosis is given as the percentage of the number of hepatocyte nuclei showing apoptotic features from the total number of hepatocyte nuclei observed.

Reverse transcriptase-polymerase chain reaction (RT-PCR)
Three hours after challenge with PBS or LPS/Gal, total RNA was extracted from whole-liver tissue using an acid guanidinium-phenol-chloroform method (TRIzol reagent) and was treated with RNase-free DNase (DNase I), according to the manufacturer’s protocol, to remove potential contamination from genomic DNA. RNA concentrations were determined by measuring the absorbance spectrophotometrically at 260 nm. RT-PCR was performed with the SuperScript one-step RT-PCR system. Each reaction contained 500 ng total liver RNA as template and 0.2 µM each primer in a final volume of 50 µL. Mouse ß-actin served as an internal control gene. The RT-PCR profile was one cycle of DNA synthesis at 50°C for 30 min, followed by 40 cycles of denaturation at 94°C for 30 s, annealing at 55°C, and extension at 72°C for 1 min, followed by one cycle of final extension at 72°C for 10 min. After RT-PCR, aliquots of the RT-PCR products were separated on 2% agarose gel containing ethidium bromide and were photographed. The primer sequences of KC, MIP-2, and ß-actin were as follows: KC (forward) 5'-GCC AAT GAG CTG CGC TGT CAA TGC-3', KC (reverse) 5'-CTT GGG GAC ACC TTT TAG CAT CTT-3'; MIP-2 (forward) 5'-GCT TCC TCG GGC ACT CCA GAC-3', MIP-2 (reverse) 5'-TTA GCC TTG CCT TTG TTC AGT AT-3'; ß-actin (forward) 5'-ATG TTT GAG ACC TTC AAC ACC-3', ß-actin (reverse) 5'-TCT CCA GGG AGG AAG AGG AT-3'.

Enzyme-linked immunosorbent assay (ELISA)
The right liver lobe was weighed and washed in PBS containing PEST (1% penicillin and streptomycin) and fungizone (100 U/ml) and was then kept cool in cold, serum-free Dulbecco’s modified Eagle’s medium (DMEM). To eluate KC and MIP-2 from the liver tissue, 50 mg of the lobe was carefully sectioned and incubated in 1 ml DMEM solution containing 10% fetal calf serum and PEST at 37°C in a 12-well plate for 24 h. The cultured medium was harvested and stored in –20°C until analysis of KC and MIP-2 by using double antibody Quantikine ELISA kits (R & D Systems Europe), using recombinant murine KC and MIP-2 as standards. The minimal detectable protein concentrations are less than 0.5 pg/ml.

Measurement of caspase-3 protease activity
Caspase-3 is an intracellular cysteine protease that becomes activated during the cascade of events associated with and required for the execution of apoptosis. Caspase-3 protease activity in the liver tissue was measured using a caspase-3 colorimetric assay kit (R & D Systems Europe) according to the manufacturer’s instructions. Briefly, after homogenization of whole-liver tissue in cell lysis buffer, homogenates were centrifuged for 1 min at 10,000 g, and the supernatant was incubated with DEVD-peptide nucleic acid (pNA) and reaction buffer for 1.5 h at 37°C. Levels of the chromophore pNA released by caspase-3 activity were quantified spectrophotometrically. The data are given as fold-increases in caspase-3 activity of test livers relative to PBS-treated control livers.

Histology
Samples were taken from the left lobe of liver and fixed in 4% formaldehyde phosphate buffer overnight. Dehydrated, paraffin-embedded, 6-µm sectionswere stained with hematoxylin and eosin and analyzed under light microscopy. The number of extravascular leukocytes was randomly quantified in five high-power fields (x400) and expressed as number of cells/mm2.

Immunohistochemistry
Liver samples were frozen (–70°) overnight in optimal cutting temperature compound (Tissue-Tek, Sakura Finetek Inc., Torrance, CA), sectioned (7 µm), and fixed in acetone. Staining of MIP-2 and KC was performed by the indirect immunoperoxidase method using a horseradish peroxidase–3'-diaminobenzidine tetrahydrochloride kit (CTS008, R & D Systems Europe) according to the manufacturer’s protocol. Tissues were incubated with 15 µg/ml primary antibody (rat anti-mouse MIP-2 and rat anti-mouse KC, R & D Systems Europe). Slides were counterstained with Mayer’s hematoxylin (Sigma Chemical Co.).

Statistical analyses
Data are presented as mean values ± SEM. Statistical evaluations were performed using Kruskal-Wallis one-way ANOVA on ranks followed by multiple comparisons versus control group (Dunn’s method). P < 0.05 was considered significant, and n represents the number of animals.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Expression of CXC chemokines
Total RNA was isolated from the liver, reverse-transcribed into cDNA, and PCR-amplified with specific primer for MIP-2 and KC. The results showed that the expression of KC mRNA and MIP-2 mRNA was low in negative controls, whereas LPS challenge caused a clear-cut expression of MIP-2 and KC mRNA (Fig. 1 ). Next, protein expression in the liver was analyzed by use of specific ELISA. The liver content of CXC chemokines in negative controls was low but detectable (n=4). Notably, the expression of MIP-2 and KC in lives of endotoxin-treated mice increased markedly from 14 ± 3 pg/mg and 8 ± 2 pg/mg in negative controls to 96 ± 11 pg/mg and 85 ± 14 mg/pg liver tissue, respectively (n=4, P<0.05 vs. negative controls). To localize the expression of CXC chemokines in endotoxemia, we examined the liver by immunohistochemistry. It is interesting that it was found that LPS increased MIP-2 expression in hepatocytes but not on the vascular endothelium (Fig . 2a and 2b ; same results were obtained for KC). Thus, it was documented that KC and MIP-2 are up-regulated in the liver during endotoxemia.



View larger version (64K):
[in this window]
[in a new window]
 
Figure 1. Expression of MIP-2 and KC mRNA in the liver. ß-actin serves as a housekeeping gene. RNA was isolated from the liver 3 h after treatment with a combination of LPS (10 µg) and D-Gal (18 mg). Negative control animals received PBS. The results presented are from one experiment, which is representative of four others performed.

 


View larger version (133K):
[in this window]
[in a new window]
 
Figure 2. Expression of MIP-2 in the liver of mice treated with (a) PBS and (b) a combination of LPS (10 µg) and D-Gal (18 mg). MIP-2 expression is primarily confined to the hepatocytes (arrows), and no expression is detected along the vascular endothelium (arrowheads) in livers of endotoxemic mice. Similar results were obtained for KC, and an isotype-matched, control antibody exhibited no unspecific staining (not shown). Original magnification, x800.

 
Leukocyte rolling and adhesion
The number of rolling and adherent leukocytes was 2.1 ± 0.4 cells/min and 0.9 ± 0.2 cells/mm, respectively, in negative-control mice (Fig . 3a and 3b ; n=6). Administration of the combination of LPS and Gal for 6 h greatly enhanced leukocyte responses in postsinusoidal venules. Indeed, endotoxin challenge increased leukocyte rolling to 12.3 ± 3.4 cells/min and firm leukocyte adhesion to 19.2 ± 2.1 cells/mm (Fig. 3a and 3b , P<0.05 vs. negative control, n=6–8). Notably, pretreatment with mAb directed against MIP-2 and KC did not decrease the numbers of intravenular leukocytes (Fig. 3a and 3b ; P>0.05 vs. control antibody, n=5). Systemic leukocyte counts were not changed by the antibody treatments (Table 1 ).



View larger version (13K):
[in this window]
[in a new window]
 
Figure 3. Leukocyte (a) rolling and (b) firm adhesion in hepatic postsinusoidal venules 6 h after treatment with a combination of LPS (10 µg) and D-Gal (18 mg) in C57 Bl/6 mice. Negative-control animals received only PBS (control). Mice were pretreated i.v. with PBS, an isotyped-matched, control antibody, and a mAb against MIP-2 (anti-MIP-2) and KC (anti-KC). Data represent means ± SEM, and n = 5–8.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Hemodynamic Parameters and Systemic Leukocyte Counts

 
Extravascular accumulation of leukocytes
Histologic examination of livers showed normal morphology in PBS-treated mice (Fig. 4A ), whereas endotoxin challenge caused severe destruction of tissue architecture with massive panlobular hemorrhage and necrosis (Fig. 4B) . Notably, immunoneutralization of MIP-2 and KC preserved the histologic structure and prevented tissue hemorrhage in endotoxemic mice (Fig. 4C and 4D) . Moreover, endotoxin challenge provoked clear-cut intra- and extravascular accumulation of leukocytes (Fig. 4B) . It is interesting to note that endotoxin-induced extravasation of leukocytes is abolished in mice treated with the antibodies against MIP-2 and KC, whereas leukocytes in the intravascular compartment remained intact in these mice. In fact, quantification of the number of extravascular leukocytes revealed that stimulation with endotoxin increased the number of extravascular leukocytes more than 26-fold, from 5.6 ± 1.0 cells/mm2 to 150.3 ± 11.5 cells/mm2 (Fig. 5 ; P<0.05 vs. negative control, n=5). Notably, immunoneutralization of MIP-2 and KC reduced tissue infiltration of leukocytes down to 26.5 ± 3.6 cells/mm2 and 25.4 ± 2.3 cells/mm2, respectively, in endotoxemic animals (Fig. 5 ; P<0.05 vs. control antibody, n=5). Combined inhibition of MIP-2 and KC did not further decrease endotoxin-induced leukocyte extravasation (Fig. 5) . Moreover, differential counts revealed that the extravasated population of leukocytes comprised more than 92% neutrophils.



View larger version (168K):
[in this window]
[in a new window]
 
Figure 4. Sections of the liver were stained with hematoxylin and eosin, and representative pictures are shown. Animals were treated with a combination of LPS (10 µg) and D-Gal (18 mg) for 6 h. (A) Negative-control animals received only PBS. Mice were pretreated i.v. with (B) a control antibody or a mAb against (C) MIP-2 and (D) KC immediately before LPS/Gal challenge. Original magnification, x400.

 


View larger version (13K):
[in this window]
[in a new window]
 
Figure 5. Extravascular leukocyte counts in liver sections stained with hematoxylin and eosin. Animals were treated with a combination of LPS (10 µg) and D-Gal (18 mg) for 6 h. Negative-control animals received only PBS. Mice were pretreated i.v. with PBS, an isotyped-matched, control antibody, and a mAb against MIP-2 (anti-MIP-2) and KC (anti-KC). Data represent means ± SEM, and n = 5–8. *, P < 0.05, versus control Ab + LPS/Gal.

 
Liver injury and perfusion
As shown in Figure 6 , endotoxin challenge provoked a significant liver injury, indicated by the increase in liver enzymes. In fact, ALT and AST were increased by more than 42-fold and 11-fold, respectively (Fig. 6a and 6b) . Indeed, immunoneutralization of MIP-2 and KC significantly protected against the LPS-induced increase in liver enzymes. Thus, the anti-MIP-2 antibody reduced ALT and AST by more than 90% and 86%, respectively, in endotoxemic mice (Fig. 6a and 6b ; P<0.05 vs. control antibody, n=5). Similarly, the anti-KC antibody decreased ALT by 94% and AST by 82% in response to LPS challenge (Fig. 6a and 6b ; P<0.05 vs. control antibody, n=5). Inhibition of MIP-2 and KC decreased the endotoxin-induced increase in ALT and AST by 92% and 76%, respectively (Fig. 6a and 6b ; P<0.05 vs. control antibody, n=5). Moreover, challenge with endotoxin deteriorated the microvascular circulation in the liver. Thus, sinusoidal perfusion was markedly reduced; i.e., the percentage of perfused sinusoids decreased from 96.1 ± 0.9% to 75.1 ± 1.7% (Fig. 7 ; P<0.05 vs. negative control, n=6–8). It is interesting that immunoneutralization of MIP-2 and KC significantly improved the sinusoidal perfusion toward baseline levels (Fig. 6 ; P<0.05 vs. control antibody, n=5). In addition, microvascular blood flow velocity and wall shear rate were significantly reduced in endotoxemic mice, which were also reversed by immunoneutralization of MIP-2 and KC (Table 1) .



View larger version (11K):
[in this window]
[in a new window]
 
Figure 6. Liver enzymes 6 h after treatment with a combination of LPS (10 µg) and D-Gal (18 mg). Negative-control animals received only PBS (control). Mice were pretreated i.v. with PBS, an isotyped-matched, control antibody, and a mAb against MIP-2 (anti-MIP-2) and KC (anti-KC). The levels of (a) ALT and (b) AST were determined spectrophotometrically. Data represent means ± SEM, and n = 5–8. *, P < 0.05, versus control Ab + LPS/Gal.

 


View larger version (16K):
[in this window]
[in a new window]
 
Figure 7. Sinusoidal perfusion in the murine liver 6 h after treatment with a combination of LPS (10 µg) and D-Gal (18 mg). Negative-control animals received only PBS (control). Mice were pretreated i.v. with PBS, an isotyped-matched, control antibody, and a mAb against MIP-2 (anti-MIP-2) and KC (anti-KC). Sinusoidal perfusion is given as the percentage of observed sinusoids with functional perfusion. Data represent means ± SEM, and n = 5–8. *, P < 0.05, versus control Ab + LPS/Gal.

 
Hepatocellular apoptosis
Apoptosis is a key feature of endotoxin-induced liver damage. Herein, we evaluated apoptosis using two different methods. First, we determined the level of apoptosis by use of the DNA-binding fluorescent dye Hoechst 33342, which stains the nuclei of hepatocytes and permits quantification of the percentage of cells with nuclear condensation and fragmentation. In negative-control mice, we found that the percentage of apoptotic hepatocytes was 6.2 ± 0.9%, which was significantly increased by endotoxin to 48.3 ± 5.5%, i.e., by almost ninefold (Fig. 8 ; P<0.05 vs. negative control, n=5–8). Notably, it was observed that immunoneutralization of KC and MIP-2 decreased endotoxin-induced apoptosis by 69% and 58%, respectively (Fig. 8 ; P<0.05 vs. control antibody, n=5–8). Combined inhibition of MIP-2 and KC reduced apoptosis by 77% in endotoxemic mice (Fig. 8 ; P<0.05 vs. control antibody, n=5–8). Next, we determined the activation of the protease caspase-3, which is an important step in hepatic parenchymal cell apoptosis. Indeed, we found that caspase-3 activity in the liver increased by almost sixfold in animals treated with endotoxin (P<0.05 vs. negative controls, n=5). It is interesting that this increase in caspase-3 activity was reduced by 68% in animals pretreated with the anti-MIP-2 antibody (P<0.05 vs. control antibody, n=5) and by 73% in anti-KC antibody-treated mice (P<0.05 vs. control antibody, n=5).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 8. Apoptosis of hepatocytes 6 h after treatment with a combination of LPS (10 µg) and D-Gal (18 mg). Negative-control animals received only PBS (control). Mice were pretreated i.v. with PBS, an isotyped-matched, control antibody, and a mAb against MIP-2 (anti-MIP-2) and KC (anti-KC). Hepatocyte apoptosis is given as the percentage of observed hepatocyte nuclei with morphological signs of apoptosis, i.e., chromatin condensation and fragmentation, after administration of the fluorochrome Hoechst 33342. Data represent means ± SEM, and n = 5–8. *, P < 0.05, versus control Ab + LPS/Gal.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This study describes an important role of CXC chemokines in leukocyte recruitment, perfusion, and hepatocellular injury in endotoxemic mice. We demonstrate that mRNA and protein levels of KC and MIP-2 in the liver increase in response to endotoxin challenge. It is interesting that our novel data demonstrate that immunoneutralization of MIP-2 and KC has no effect on intravascular accumulation of leukocytes, whereas leukocyte recruitment into the extravascular space of the hepatic parenchyma is abolished. In parallel to this reduction in leukocyte transmigration, we found that inhibition of MIP-2 and KC restored microvascular perfusion and attenuated the hepatocellular injury and apoptosis induced by endotoxin challenge. Taken together, these findings indicate that MIP-2 and KC play a key role in extravascular trafficking of leukocytes in septic liver injury and that CXC chemokines constitute potential targets to control endotoxin-provoked liver injury.

It is widely held that infiltration and activation of leukocytes constitute a rate-limiting step in endotoxin-induced liver injury [1 2 3 ]. We have recently shown that leukocyte recruitment is a multistep process, initiated by selectin-mediated rolling [3 ], mainly P-selectin [4 ], in postsinusoidal venules in response to endotoxemia. Moreover, it has been documented that CD18 mediates stationary adhesion of leukocytes to the endothelium in hepatic venules [3 ]. In this context, it should be mentioned that some studies have suggested that also the associated sinusoidal sequestration of leukocytes may contribute to hepatocellular liver injury, although a definitive contribution of sinusoidal leukocytes to the tissue damage remains controversial [3 8 24 25 ]. An accumulating body of evidence suggests that chemokines are the main group of molecules regulating tissue trafficking of leukocytes in several disease models [10 14 15 16 17 ]. Considering that MIP-2 and KC are up-regulated in endotoxemia, as shown herein and previously [18 19 ], it is imperative to learn more about the role of these CXC chemokines, not only for a deeper pathophysiologic understanding but also as such knowledge is critical in the development of novel, anti-inflammatory strategies directed against septic liver injury. However, the limited published literature on the role of MIP-2 and KC in endotoxin-induced leukocyte infiltration is complex and partly contradictory. For example, one group has observed that administration of an antibody directed against the CXC chemokine, cytokine-induced neutrophil chemoattractant reduces LPS-provoked neutrophil accumulation in the rat liver [18 ], whereas others have reported that immunoneutralization of MIP-2 and KC has no inhibitory effect on LPS-induced recruitment of neutrophils in the liver [20 ]. These discrepancies cannot be resolved at present but may be related to the use of different species or antibodies. In the present study, we found that passive immunization against MIP-2 and KC effectively reduced hepatic infiltration of leukocytes. Although pretreatment of mice with the anti-MIP-2 and anti-KC antibodies had no effect on endotoxin-induced leukocyte rolling and adhesion inside the liver microvessles, we found that they abolished (83% reduction) extravascular accumulation of leukocytes in the liver elicited by LPS. One feasible explanation is that the anti-CXC chemokine antibodies break the chemotactic gradient created by hepatocytes in response to endotoxin challenge, which in turn disturbs the extravasation process of leukocytes. Indeed, this notion is supported by our observation that CXC chemokines are mainly expressed in hepatocytes and not on the endothelium in endotoxemia. Thus, these findings suggest that intravascular leukocyte-endothelium interactions are not dependent on CXC chemokines but may be triggered by other leukocyte-activating substances, such as platelet-activating factor and products of the complement system [26 27 ]. Alternatively, CXC chemokines may not be sufficiently potent to trigger leukocyte adhesion inside the liver microvasculature. In fact, the latter hypothesis is supported by a previous study reporting that tumor necrosis factor {alpha} and interleukin-1 are markedly more potent inducers of venular leukocyte accumulation than CXC chemokines in the liver [21 ].

Tissue recruitment of leukocytes is a key component in immune surveillance and host-defense reactions [28 ]. However, under various circumstances, the activation and infiltration of leukocytes result in tissue damage in certain diseases, including ischemia-reperfusion injury, graft rejection, and endotoxemia [5 ]. In the present study, we found that immunoneutralization of MIP-2 and KC not only abrogated leukocyte extravasation but also decreased hepatocellular injury by 82–94% and restored sinusoidal perfusion, suggesting that CXC chemokine-mediated leukocyte recruitment plays a critical role in septic liver injury. Considering that MIP-2 and KC bind to the same receptor, CXC chemokine receptor 2, it was of interest to test combined inhibition of MIP-2 and KC in this model. We found that blocking both CXC chemokines was similarly effective against endotoxin-induced leukocyte recruitment as inhibition of MIP-2 or KC alone, suggesting that MIP-2 and KC are necessary for the liver phenotype in endotoxemia. A key role of leukocytes has been documented previously by demonstrating that neutrophil depletion markedly attenuates LPS-provoked liver injury [29 ]. A number of mechanisms of neutrophil-mediated tissue injury have been forwarded. For example, neutrophils are potent producers of reactive oxygen species (ROS), such as hydroxyl radicals and superoxide, which exert harmful effects on hepatocytes and endothelial cells in the liver [30 ]. Indeed, we have recently observed that inhibition of ROS production protects against LPS-induced liver injury [31 ]. It is interesting that we also found that ROS regulates CXC chemokine expression in septic liver injury [31 ], emphasizing the importance of oxidant stress in endotoxemia. In this context, it is noticeable that we observed that inhibition of CXC chemokines reduced leukocyte extravasation (83% reduction) without affecting intravascular accumulation of leukocytes. Thus, our data demonstrate that CXC generation induced by endotoxin challenge is mainly important for the transmigration of leukocytes in the liver. These findings are compatible with the concept that extravasation out of the vessels is necessary for leukocytes to cause injurious impact on the liver parenchyma [8 ].

Hepatocyte apoptosis is a prominent and important feature in septic liver injury. In this context, it is interesting to note that one recent investigation has shown that engagement of Fas receptors not only causes cell death but also stimulates local production of CXC chemokines in the liver [32 ]. Moreover, Jaeschke and co-workers [24 ] have forwarded the possibility that endotoxin challenge provokes apoptosis before the onset of leukocyte recruitment. It is interesting that we found that immunoneutralization of MIP-2 and KC significantly decreased endotoxin-induced apoptosis by more than 58% in the liver, indicating that CXC chemokine-mediated neutrophil infiltration contributes to apoptosis in septic liver injury. Considered together, it may be suggested that there is an escalating mechanism in the liver, involving chemokine-induced neutrophil recruitment, which causes apoptosis on one hand, and apoptosis-induced secretion of chemokines, which causes neutrophil infiltration on the other.

Taken together, these novel results demonstrate that CXC chemokines constitute an integral part of the pathophysiology in endotoxemic liver injury by triggering leukocyte extravasation. Inhibition of MIP-2 and KC function attenuated not only tissue recruitment of leukocytes but also preserved microvascular perfusion and reduced hepatocellular injury and apoptosis. Conversely, intravascular accumulation of leukocytes is independent of MIP-2 and KC function. In conclusion, our data indicate that CXC chemokines may be useful targets to protect against excessive inflammation in septic liver injury.


    ACKNOWLEDGEMENTS
 
This work was supported by grants from the Swedish Medical Research Council (K2000-04P-13411-01A, K2002-73-X-14273-01A), Crafoordska stiftelsen, Blanceflors stiftelse, Einar och Inga Nilssons stiftelse, Harald och Greta Jaenssons stiftelse, Greta och Johan Kocks stiftelser, Fröken Agnes Nilssons stiftelse, Franke and Margareta Bergqvists stiftelse för främjande av cancerforskning, Mossbergs stiftelse, Nanna Svartz stiftelse, Ruth och Richard Julins stiftelse, Svenska Läkaresällskapet, Teggers stiftelse, Allmäna sjukhusets i Malmö stiftelse för bekämpande av cancer, MAS fonder, Malmö University Hospital, and Lund University. We thank Yusheng Wang and René Schramm for excellent technical assistance. X. L. and D. K. contributed equally to the work.

Received June 27, 2003; revised October 8, 2003; accepted October 21, 2003.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Holman, J. M., Jr, Saba, T. M. (1988) Hepatocyte injury during post-operative sepsis: activated neutrophils as potential mediators J. Leukoc. Biol. 43,193-203[Abstract]
  2. Jaeschke, H., Farhood, A., Smith, C. W. (1991) Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism Am. J. Physiol. 261,G1051-G1056
  3. Klintman, D., Schramm, R., Menger, M. D., Thorlacius, H. (2002) Leukocyte recruitment in hepatic injury: selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesion J. Hepatol. 36,53-59[Medline]
  4. Klintman, D., Xiang, L., Thorlacius, H. (2004) Important role of P-selectin in leukocyte recruitment, hepatocellular injury and apoptosis in endotoxemic mice Clin. Diagn. Lab. Immunol. 11,56-62[Abstract/Free Full Text]
  5. Carlos, T. M., Harlan, J. M. (1994) Leukocyte-endothelial adhesion molecules Blood 84,2068-2101[Abstract/Free Full Text]
  6. Wakelin, M. W., Sanz, M. J., Dewar, A., Albeda, S. M., Larkin, S. W., Boughton-Smith, N., Williams, T. J., Nourshargh, S. (1996) An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane J. Exp. Med. 184,229-239[Abstract/Free Full Text]
  7. Chosay, J. G., Fisher, M. A., Farhood, A., Ready, K. A., Dunn, C. J., Jaeschke, H. (1998) Role of PECAM-1 (CD31) in neutrophil transmigration in murine models of liver and peritoneal inflammation Am. J. Physiol. 274,G776-G782
  8. Chosay, J. G., Essani, N. A., Dunn, C. J., Jaeschke, H. (1997) Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury Am. J. Physiol. 272,G1195-G1200
  9. Rollins, B. J. (1997) Chemokines Blood 90,909-928[Free Full Text]
  10. Bacon, K. B., Oppenheim, J. J. (1998) Chemokines in disease models and pathogenesis Cytokine Growth Factor Rev. 9,167-173[CrossRef][Medline]
  11. Zlotnik, A., Morales, J., Hedrick, J. A. (1999) Recent advances in chemokines and chemokine receptors Crit. Rev. Immunol. 19,1-47[Medline]
  12. Tekamp-Olson, P., Gallegos, C., Bauer, D., McClain, J., Sherry, B., Fabre, M., Van Deventer, S., Cerami, A. (1990) Cloning and characterization of cDNAs for murine macrophage inflammatory protein-2 and its human homologues J. Exp. Med. 172,911-919[Abstract/Free Full Text]
  13. Oquendo, P., Alberta, J., Wen, D. Z., Graycar, J. L., Derynck, R., Stiles, C. D. (1989) The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet {alpha}-granule proteins J. Biol. Chem. 264,4133-4137[Abstract/Free Full Text]
  14. Schmal, H., Shanley, T. P., Jones, M. L., Friedl, H. P., Ward, P. A. (1996) Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats J. Immunol. 156,1963-1972[Abstract]
  15. Feng, L., Xia, Y., Yoshimura, T., Wilson, C. B. (1995) Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody J. Clin. Invest. 95,1009-1017
  16. Diab, A., Abdalla, H., Li, H. L., Shi, F. D., Zhu, J., Hojberg, B., Lindquist, L., Wretlind, B., Bakhiet, M., Link, H. (1999) Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1 {alpha} attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis Infect. Immun. 67,2590-2601[Abstract/Free Full Text]
  17. Lentsch, A. B., Yoshidome, H., Cheadle, W. H., Miller, F. N., Edwards, M. J. (1998) Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for MIP-2 and KC Hepatology 27,1172-1177[CrossRef][Medline]
  18. Zhang, P., Xie, M., Zagorski, J., Spitzer, J. A. (1995) Attenuation of hepatic sequestration by anti-CINC antibody in endotoxic rats Shock 4,262-268[Medline]
  19. Rovai, L. E., Herschman, H. R., Smith, J. B. (1998) The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia J. Leukoc. Biol. 64,494-502[Abstract]
  20. Jaeschke, H., Hopper, R. D., Lawson, J. A., Remick, D. G., Farhood, A. (1999) Transcriptional activation and functional role of the CXC chemokines MIP-2 and KC for neutrophil-induced liver injury during endotoxemia Hepatology 30(Suppl.),411A(abstract)
  21. Bajt, M. L., Farhood, A., Jaeschke, H. (2001) Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature Am. J. Physiol. Gastrointest. Liver Physiol. 281,G1188-G1195[Abstract/Free Full Text]
  22. House, S. D., Lipowsky, H. H. (1987) Leukocyte endothelium adhesion: microhaemodynamics in the mesentery of the cat Microvasc. Res. 34,363-379[CrossRef][Medline]
  23. Rauen, U., Polzar, B., Stephan, H., Mannherz, H. G., de Groot, H. (1999) Cold-induced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species FASEB J. 13,155-168[Abstract/Free Full Text]
  24. Lawson, J. A., Fisher, M. A., Simmons, C. A., Farhood, A., Jaeschke, H. (1998) Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury Hepatology 28,761-767[CrossRef][Medline]
  25. Vollmar, B., Glasz, M. D., Menger, M. D., Messmer, K. (1995) Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence Surgery 117,195-200[CrossRef][Medline]
  26. Lehmann, T. G., Koeppel, T. A., Munch, S., Heger, M., Kirschfink, M., Klar, E., Post, S. (2001) Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia Microvasc. Res. 62,284-292[CrossRef][Medline]
  27. Komatsu, Y., Shiratori, Y., Hikiba, Y., Hashimoto, N., Han, K., Kawase, T., Yoshida, H., Okano, K., Omata, M. (1996) Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury Dig. Dis. Sci. 41,1030-1037[CrossRef][Medline]
  28. Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76,301-314[CrossRef][Medline]
  29. Hewett, J. A., Jean, P. A., Kunkel, S. L., Roth, R. A. (1993) Relationship between tumor necrosis factor-{alpha} and neutrophils in endotoxin-induced liver injury Am. J. Physiol. 265,G1011-G1015
  30. Spolarics, Z. (1998) Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid J. Leukoc. Biol. 63,534-541[Abstract]
  31. Klintman, D., Xiang, L., Thorlacius, H. (2003) Allopurinol inhibits expression of CXC chemokines and leukocyte recruitment in septic liver injury Inflamm. Res. 52,353-358[CrossRef][Medline]
  32. Faouzi, S., Burckhardt, B. E., Hanson, J. C., Campe, C. B., Schrum, L. W., Rippe, R. A., Maher, J. J. (2001) Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-{kappa}B-independent, caspase-3-dependent pathway J. Biol. Chem. 276,49077-49082[Abstract/Free Full Text]

Related Articles

Critical role of CXC chemokines in endotoxemic liver injury in mice
Hartmut Jaeschke and Mary Lynn Bajt
J. Leukoc. Biol. 2004 76: 1089-1090. [Full Text] [PDF]

Response to the letter by Dr. Jaeschke
Henrik Thorlacius and Daniel Klintman
J. Leukoc. Biol. 2004 76: 1091-1092. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. W. Ng, H. Zhang, A. Hegde, and M. Bhatia
Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia
J. Leukoc. Biol., February 1, 2008; 83(2): 288 - 295.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Buanne, E. Di Carlo, L. Caputi, L. Brandolini, M. Mosca, F. Cattani, L. Pellegrini, L. Biordi, G. Coletti, C. Sorrentino, et al.
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice
J. Leukoc. Biol., November 1, 2007; 82(5): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. L. Patrick, J. Rullo, S. Beaudin, P. Liaw, and A. E. Fox-Robichaud
Hepatic leukocyte recruitment in response to time-limited expression of TNF-{alpha} and IL-1beta
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G663 - G672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. W. Laschke, M. D. Menger, Y. Wang, G. Lindell, B. Jeppsson, and H. Thorlacius
Sepsis-associated cholestasis is critically dependent on P-selectin-dependent leukocyte recruitment in mice
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1396 - G1402.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Thorlacius, J. E. Slotta, M. W. Laschke, Y. Wang, M. D. Menger, B. Jeppsson, and H. Thorlacius
Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury
J. Leukoc. Biol., May 1, 2006; 79(5): 923 - 931.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, X. Deng, J. F. Maddox, P. E. Ganey, et al.
Coagulation-Dependent Gene Expression and Liver Injury in Rats Given Lipopolysaccharide with Ranitidine but Not with Famotidine
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 635 - 643.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
O. Kollmar, C. Scheuer, M. D. Menger, and M. K. Schilling
Macrophage Inflammatory Protein-2 Promotes Angiogenesis, Cell Migration, and Tumor Growth in Hepatic Metastasis
Ann. Surg. Oncol., February 1, 2006; 13(2): 263 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Van Lint, B. Wielockx, L. Puimege, A. Noel, C. Lopez-Otin, and C. Libert
Resistance of Collagenase-2 (Matrix Metalloproteinase-8)-Deficient Mice to TNF-Induced Lethal Hepatitis
J. Immunol., December 1, 2005; 175(11): 7642 - 7649.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. B. Dorman, J. S. Gujral, M. L. Bajt, A. Farhood, and H. Jaeschke
Generation and functional significance of CXC chemokines for neutrophil-induced liver injury during endotoxemia
Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G880 - G886.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. A. Johnston, J. P. Mizgerd, and S. A. Shore
CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L61 - L67.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Jaeschke and M. L. Bajt
Critical role of CXC chemokines in endotoxemic liver injury in mice
J. Leukoc. Biol., December 1, 2004; 76(6): 1089 - 1090.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Thorlacius and D. Klintman
Response to the letter by Dr. Jaeschke
J. Leukoc. Biol., December 1, 2004; 76(6): 1091 - 1092.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0603297v1
75/3/443    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X.
Right arrow Articles by Thorlacius, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X.
Right arrow Articles by Thorlacius, H.
Related Collections